NASDAQ Company offers Life Saving Medical Advances; AI & Immunotherapy for Cancer & Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO) AVCO Filtration … Read More
Breakthrough Medicine: Escozine uses peptides obtained from Scorpion Venom to create alternative oncological medicines for Multiple Medical Conditions Including Covid-19 and Cancer: Quanta Inc., (Stock … Read More
Leading Edge Cyber-Security Solutions at Every Level for an Expanding Range of Clients Worldwide: Safe-T Group Ltd. (Nasdaq: SFET) (Israel Market: TASE) SFET’s Newest Consumer … Read More
Year End Update for this Up & Coming NASDAQ at the forefront of innovations in healthcare Featuring AI & Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is … Read More
Advances for Tourette Syndrome, Alzheimer’s Disease, Pain Management, Autism Spectrum Disorder & Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC) SPRC Issued U.S. Patent For … Read More
NASDAQ Company at the forefront of innovations in healthcare: Avalon GloboCare Corp. (NASDAQ:AVCO) has AI-Enhanced Protein Design Technology for Cellular Therapy Development AVCO’s Chairman Converts $3.0 … Read More
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO), Palantir Technologies (NYSE: PLTR) and Nvidia (NVDA) lead the Charge and Artificial Intelligence (AI) is at the forefront of innovations … Read More
Profitable, Low Share Structure; Top Quality Health & Wellness Brands to Serve a Growing Global Consumer Demand: Rapid Nutrition PLC (OTCQB: RPNRF) – Multi-Product Line … Read More
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO) – Clinical-Stage CellTech Developer Dedicated to Immune Effector Cell … Read More
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals. Leading Drug Developer and Manufacturer of … Read More
Supplier of Non-Invasive Cardiac Monitoring Systems Expanding Via New Partnerships & OTCQB Uplisting Efforts: CB Scientific Stock Symbol: CBSC CB Scientific, Inc. (CBSC) Executes Manufacturing … Read More
NASA, Lockheed Martin & Many Government Agencies use this NYSE Company’s Products: KULR Technology Group, Inc. (NYSE American: KULR) Leading-Edge Developer of Carbon Fiber Thermal … Read More
PHUN MaaS Available on AMZN; Ground Breaking Mobile Data Applications for Multiscreen-as-a-Service (MaaS) Available on Amazon Web Services Marketplace: Phunware, Inc. (NASDAQ: PHUN) … Read More
Clean Vision’s Clean-Seas Acquires Pyrolysis Plant for Deployment in India; Activates Previously Announced MOU with India’s IICT in the World’s Second Largest Renewable Energy Market. … Read More
TLRY is Making waves along with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: … Read More
High Tech NASDAQ Developer Making Key Advancements in Multiple Business Sectors: New Joint Venture to Trade NFT Assets, Investing up to $5M: Medigus Ltd. (NASDAQ: … Read More
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW) Breaking News: JUPITER, … Read More
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS) – Holistic Approach to Patient-First Health and Wellness … Read More
This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer & Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO) … Read More
IPO Launch on the NASDAQ; $31.6 Million Dollar Raise; Clinical Trials Underway on Key Female Oriented Healthcare Advances: Femasys (NASDAQ: FEMY) – Commitment and Company … Read More
25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials … Read More
25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials … Read More
New 4.1 Million Dollar Order; Advanced Marine Survey Tech Serving Both Military & Civilian Clients Worldwide: MIND Technology, Inc. (NASDAQ: MIND) – High Performance Marine … Read More
22 Million in Cash for this NASDAQ insures Operating Capital into Mid 2022; FDA Review of ACER 001 Bodes well for Acer Therapeutics Inc. (NASDAQ: … Read More
Strong Cash Position of $43.2 Million Provides Runway into 2nd half of 2023 to Advance the Company’s Programs for Gain Therapeutics, Inc. (NASDAQ: GANX) – Two … Read More
Marine Survey Technology from this Nasdaq Company is Serving Both Military & Civilian Clients Worldwide: MIND Technology, Inc. (NASDAQ: MIND) – High Performance Marine Sonar … Read More
Capital Efficient: Clinical Stage NASDAQ Company – Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials Progressing on Multiple Novel Cancer Treatments. … Read More
Ad hoc announcement pursuant to Art. 53 LR BAAR, Switzerland (Viz Release) August 6, 2021 – – Blackstone Resources AG (SWX: BLS) is pleased to … Read More
Ad hoc announcement pursuant to Art. 53 LR BAAR, Switzerland (Viz Release) August 4, 2021 – – Blackstone Resources AG (SWX: BLS) is pleased to … Read More
This NASDAQ is Unlocking New Treatments for Neurodegenerative and Lysosomal Storage Diseases: Gain Therapeutics, Inc. (NASDAQ: GANX) – Two Patents on Modulator Compounds for Treatment … Read More